Devices › Device types
FDA product code DQO · class 2 · Cardiovascular
Catheter, intravascular, diagnostic: medical device reports filed with FDA
20,198 reports carry this product code, 1992–2026; 30 brands with a page.
- 20,198
- reports with this product code
- 0.1% of all MAUDE reports
- 843
- reports, 12 months to August 2026
- 602 in the 12 months before
- 56%
- classified as malfunction
- 62.3% across all reports
- 2.2%
- classified as death, as reported
- 0.9% across all reports
Product code DQO is FDA's classification for "Catheter, intravascular, diagnostic" (cardiovascular panel), a class 2 device. 20,198 medical device reports carry this product code, 0.1% of the MAUDE database, from March 1992 to August 2026.
843 reports arrived in the 12 months to August 2026, up 40% from 602 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (56%), injury (37.6%) and other (3.1%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Merit Custom Kit | 1,062 | 13 | 0.1% | 96.7% |
| Ultrasonic Imaging Catheter - Coronary | 569 | 0 | 0% | 98.6% |
| Trapease Pvcf Fem/Jug 55cm Csi | 283 | 0 | 3.7% | 0% |
| 466p306x | 263 | 0 | 1.8% | 1.8% |
| Renegade | 260 | 0 | 0.3% | 95.7% |
| Infiniti | 259 | 141 | 0% | 92.1% |
| Tempo | 246 | 155 | 0.7% | 58.3% |
| Impress Braided Catheter | 215 | 0 | 0% | 16.7% |
| Impress | 200 | 25 | 1% | 27.5% |
| Impress Peripheral Catheter | 186 | 0 | 0% | 36.6% |
| Dragonfly OpStar | 183 | 88 | 0.5% | 83.4% |
| V-Cath | 146 | 0 | 1.7% | 14.3% |
| Arrow | 126 | 65 | 3.4% | 66.7% |
| Bard | 123 | 2 | 1.8% | 31.1% |
| Trapease Filter | 120 | 0 | 13.9% | 11.5% |
| Guide Wires | 104 | 0 | 1.6% | 55.1% |
| Groshong Catheter | 85 | 58 | 1.9% | 47.1% |
| Cook | 55 | 6 | 2.2% | 45% |
| Unknown Trapease Vena Cava Filter | 35 | 0 | 1.9% | 0% |
| Vista Brite Tip | 25 | 67 | 0% | 94.3% |
| First Picc Peripherally Inserted Central Catheter | 19 | 0 | 1.8% | 0% |
| First Picc | 18 | 0 | 0.4% | 72.8% |
| Cordis | 17 | 0 | 9.3% | 20.6% |
| Flexima? | 16 | 10 | 0.4% | 75.5% |
| Ra Cath Set 20 Ga X 1-3/4 | 15 | 0 | 0% | 77.7% |
| Catheter | 13 | 9 | 3.7% | 27.9% |
| Unknown Vena Cava Filter | 11 | 0 | 3.3% | 5.2% |
| Acuson | 10 | 0 | 0.4% | 92.9% |
| OptiCross | 10 | 136 | 0.9% | 87.2% |
| Premicath | 10 | 54 | 3.6% | 69.8% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Merit Medical Systems | 2,143 | 10.6% |
| Bard Access Systems | 1,776 | 8.8% |
| Cook | 916 | 4.5% |
| Arrow International | 857 | 4.2% |
| Arrow Intl | 800 | 4% |
| Cordis | 704 | 3.5% |
| Cordis Cashel | 682 | 3.4% |
| Cordis De Mexico | 643 | 3.2% |
| Cordis US | 602 | 3% |
| Boston Scientific - Fremont Sud | 505 | 2.5% |
| Angiodynamics | 356 | 1.8% |
| Boston Scientific - Costa Rica Coyol | 320 | 1.6% |
| C R Bard Basd | 249 | 1.2% |
| Terumo Ashitaka | 246 | 1.2% |
| Mallinckrodt Medical | 209 | 1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Breakthe device broke | 2,793 | 13.8% |
| Material separation | 1,973 | 9.8% |
| Difficult to removethe device was hard to remove | 1,748 | 8.7% |
| Fracturea broken bone | 1,581 | 7.8% |
| Leak/splashthe device leaked | 1,256 | 6.2% |
| Implant, removal of | 1,181 | 5.8% |
| Replace | 1,111 | 5.5% |
| Explanted | 969 | 4.8% |
| Detachment of device component | 771 | 3.8% |
| Retraction problem | 720 | 3.6% |
| Difficult to insertthe device was hard to insert | 711 | 3.5% |
| Tip breakage | 677 | 3.4% |
| Crackthe device cracked | 676 | 3.3% |
| Migration or expulsion of device | 636 | 3.1% |
| Device, removal of (non-implant) | 628 | 3.1% |
| Detachment of device or device componentpart of the device came off | 610 | 3% |
| Device contamination with chemical or other material | 575 | 2.8% |
| Fluid/blood leak | 504 | 2.5% |
| Device, or device fragments remain in patient | 484 | 2.4% |
| Kinkedthe tube or line kinked | 461 | 2.3% |
Questions about catheter, intravascular, diagnostic reports
What is product code DQO?
FDA's classification code for "Catheter, intravascular, diagnostic", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
20,198 reports through August 2026, 843 of them in the latest 12 months.
Which brands appear most often?
Merit Custom Kit (1,062), Ultrasonic Imaging Catheter - Coronary (569), Trapease Pvcf Fem/Jug 55cm Csi (283), 466p306x (263) and Renegade (260). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.